Women In Perimenopause Report More Anxiety Than Other Menopausal Groups
A review of 24,523 women found higher odds of reported anxiety during perimenopause and after menopause than before it; the evidence does not show causation.
Novel ADC Achieves Impressive PFS Advantage In HER2-Low Metastatic Breast Cancer
In China’s phase III APEX-Breast01 trial, TQB2102 extended median PFS to 16.4 months versus 5.5 months with chemotherapy; survival data remain preliminary.